Zydus Lifesciences Limited (ZYDUSLIFE) Share Price
NSE · Healthcare · Drug Manufacturers - Specialty & Generic · ISIN INE010B01027
Key metrics
- Market Cap
- ₹1.13 L Cr
- P/E Ratio
- 25.3
- EPS
- 44.9
- Book Value
- 293.99
- P/B Ratio
- 3.86
- ROE
- 17.04%
- ROCE
- 13.75%
- Debt / Equity
- 0.42
- Net Margin
- 18.86%
- Revenue Growth
- 18.37%
- Profit Growth
- 11.37%
- Dividend Yield
- 0.09%
- 52W High
- ₹1,205.00
- 52W Low
- ₹835.50
- Market Cap Band
- large cap
- Face Value
- 1
Ratios computed from the annual results period ending 2026-03-31.
About Zydus Lifesciences Limited
Zydus Lifesciences Limited engages in the research, development, production, marketing, distribution, and sale of pharmaceutical products in India, the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Consumer Products, and Medical Technologies. The company offers active pharmaceutical ingredients, human and finished dosage formulations, generics, branded generics, specialty formulations, biosimilars, vaccines, novel therapeutics, medical devices and technologies, consumer wellness, veterinary, and animal health products. It also provides biological products in the areas of oncology, autoimmune disorders, nephrology, inflammation, rheumatology, hepatology, and infectious diseases; and designs and executes clinical trials across new chemical entities (NCEs), biologics, vaccines, and specialty generics. In addition, the company operates seasonal, skin and healthcare, and food and nutrition products under the Glucon D, Complan, Sugar Free, Nycil, Everyuth, Nutralite, and RiteBite Max Protein brands. The company was formerly known as Cadila Healthcare Limited and changed its name to Zydus Lifesciences Limited in February 2022. Zydus Lifesciences Limited was founded in 1952 and is headquartered in Ahmedabad, India. Zydus Lifesciences Limited is a subsidiary of Zydus Family Trust.
- Headquarters
- Ahmedabad, India
- Employees
- 29,980
- Promoter Holding
- 75.19%
The full Zydus Lifesciences Limited analysis
Create a free account to open the complete ZYDUSLIFE deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.